Clinical effect of Danhong injection combined with edaravone in patients with idiopathic pulmonary fibrosis and influence on TNF-α and TGF-β1 in serum
- VernacularTitle:丹红注射液联合依达拉奉治疗特发性肺纤维化患者的临床疗效及对血清TNF-α和TGF-β1水平的影响
- Author:
Yun SUN
;
Yaqing LI
;
Xiaodong LV
- Publication Type:Journal Article
- Keywords:
Danhong injection;
edaravone;
idiopathic pulmonary fibrosis;
PaO2;
TGF-β1
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;35(10):38-40
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical effect of Danhong injection combined with edaravone in patients with idiopathic pulmonary fibrosis (IPF) and influence on TNF-αand TGF-β1 in serum.Methods 67 patients were randomly divided into Treatment Group (n=35) and Control Group (n=32) in Xuanwu hospital of Nanjing from March 2011 to December 2014.All the patients were treated by comprehensive conventional treatment, and then control group was treated by edaravone, treatment group were treated by Danhong injection on the basis of control group.The clinical efficiency, PaO2 , carbon monoxide diffusing capacity (Dlco) and the levels of inflammatory factors between two groups were compared.Results After treatment, the clinical total effective rate(97.14%) of treatment group was statistically higher than that of control group (75.00%, Z=-2.035,P=0.042).After treatment, partial pressure of oxygen(PaO2) and Dlco in treatment group were increased significantly(all P<0.05);and it was statistically higher then control group (all P<0.05).TNF-αand TGF-β1 in treatment group were decreased significantly (all P<0.05);and it was also statistically higher then control group (all P<0.05).Conclusion Danhong injection combined with edaravone is effective in treatment of IPF, which can significantly improve the pulmonary function and levels of inflammatory factors.
